Could a common immune treatment ease sickle cell pain?
NCT ID NCT01757418
First seen Nov 17, 2025 · Last updated May 16, 2026 · Updated 28 times
Summary
This study tested whether a medicine called Intravenous Immunoglobulin (IVIG) is safe and works for treating sudden, severe pain episodes in people with sickle cell disease. About 300 people took part. The goal was to see if IVIG could shorten the pain crisis and reduce the need for strong painkillers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Montefiore Medical Center
The Bronx, New York, 10467, United States
Conditions
Explore the condition pages connected to this study.